| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.16 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.09 | 0.1 |